Pfizer

Opportunities for Western CDMOs in China

Pfizer Loses Lyrica Patent Fight

A Wide Spectrum of Contract Services

Pfizer Splits into Three Businesses

Pfizer to Reverse Hikes after Trump Scolds

UK Overturns Pfizer Fine for Epilepsy Drug

Pfizer Under Pressure in EpiPen Shortage

Pfizer pays to settle US Kickback Charge

Along the Acquisition Trail

Pfizer and Allogene in Cancer Therapy Pact

Pfizer Left Holding Consumer Health Bag

Interest in Consumer Drug Buys Waning?

Johnson & Johnson Loses Another Patent Suit

Management Reshuffle at GlaxoSmithKline

Jacobs Wins PDH/Gene Therapy Contracts

UK Watchdog Finds Concordia Guilty of Market Abuse

FDA Approves new Two-drug HIV Treatment

The German Capital Region

The German capital region is one of the leading life sciences and healthcare industries centers in the world. A total of around 30,000 employees work in more than 500 companies in the pharma, the biotech and the medtech industry.

Roche Sues Pfizer to Block Herceptin Copy

Pfizer Sells Stake in Chinese JV with Hisun

Pfizer to Launch Consumer Health Sale Soon?

Pharma Bribes Reportedly Aided iraq Terrorism

Pfizer Mulls Sale of Consumer Health Unit

Pfizer Sues J&J over Arthritis Drug

Merck KGaA May Sell Consumer Health

J&J Protests Death Row Use of its Drug

Merck KGaA and iOnctura in new JV

Pfizer and Sangamo Link on Hemophilia A

Pfizer Gives NHS Breast Cancer Drug Free

Drug Patent Losses Worth Billions Seen in 2017

Pharma Chiefs Call for Decision on EMA

Death Penalty Drugs Under Scrutiny Again

Pfizer CEO Criticizes US Healthcare

Pfizer Said Looking for Gene Therapy Site

Concordia and Actavis UK Accused of Overpricing